Targeted and stable gene delivery into muscle cells by a two-step transfer system

被引:2
作者
Fujii, I
Suzuki, S
Igarashi, T
Matsukura, M
Miike, T
Shimada, T
机构
[1] Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1138602, Japan
[2] Nippon Med Sch, Div Gene Therapy Res, Ctr Adv Med Technol, Bunkyo Ku, Tokyo 1138602, Japan
[3] Kumamoto Univ, Sch Med, Dept Child Dev, Kumamoto 860, Japan
关键词
D O I
10.1006/bbrc.2000.3382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We developed a muscle-specific gene delivery system based on two-step gene transfer. The first step involved adenovirus-mediated transfer of the ecotropic retrovirus receptor (EcoRec) gene driven by the muscle-specific desmin promoter. Both human primary myoblasts and fibroblasts were efficiently transduced with this adenovirus vector. However, expression of EcoRec was detected only in myoblasts, In the second step, EcoRec-expressing myoblasts could be stably transduced with the ecotropic retroviral vector with the P-galactosidase gene. Approximately 15% of myoblasts were transduced by this two-step strategy, When the transduced myoblasts were differentiated into myotubes, extensive cell-cell fusion occurred, and the apparent number of P-galactosidase-positive cells increased to 28%, These results indicate that our two-step gene delivery system could be used for targeted and stable gene transfer into muscle cells. (C) 2000 Academic Press.
引用
收藏
页码:931 / 935
页数:5
相关论文
共 32 条
[1]   A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo [J].
Bowles, NE ;
Eisensmith, RC ;
Mohuiddin, R ;
Pyron, M ;
Woo, SLC .
HUMAN GENE THERAPY, 1996, 7 (14) :1735-1742
[2]   CROSS-REACTIVE LYSIS OF HUMAN TARGETS INFECTED WITH PROTOTYPIC AND CLINICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRAINS BY MURINE ANTI-HIV-1 IIIB ENV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES [J].
CHADA, S ;
DEJESUS, CE ;
TOWNSEND, K ;
LEE, WTL ;
LAUBE, L ;
JOLLY, DJ ;
CHANG, SMW ;
WARNER, JF .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3409-3417
[3]  
Chong H, 1996, GENE THER, V3, P624
[4]   NO RETROVIREMIA OR PATHOLOGY IN LONG-TERM FOLLOW-UP OF MONKEYS EXPOSED TO A MURINE AMPHOTROPIC RETROVIRUS [J].
CORNETTA, K ;
MORGAN, RA ;
GILLIO, A ;
STURM, S ;
BALTRUCKI, L ;
OREILLY, R ;
ANDERSON, WF .
HUMAN GENE THERAPY, 1991, 2 (03) :215-219
[5]   AMPHOTROPIC MURINE LEUKEMIA RETROVIRUS IS NOT AN ACUTE PATHOGEN FOR PRIMATES [J].
CORNETTA, K ;
MOEN, RC ;
CULVER, K ;
MORGAN, RA ;
MCLACHLIN, JR ;
STURM, S ;
SELEGUE, J ;
LONDON, W ;
BLAESE, RM ;
ANDERSON, WF .
HUMAN GENE THERAPY, 1990, 1 (01) :15-30
[6]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436
[7]   RETROVIRAL RETARGETING BY ENVELOPES EXPRESSING AN N-TERMINAL BINDING DOMAIN [J].
COSSET, FL ;
MORLING, FJ ;
TAKEUCHI, Y ;
WEISS, RA ;
COLLINS, MKL ;
RUSSELL, SJ .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6314-6322
[8]   CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].
DAI, YF ;
SCHWARZ, EM ;
GU, DL ;
ZHANG, WW ;
SARVETNICK, N ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405
[9]   Improved detection of replication-competent retrovirus [J].
Forestell, SP ;
Dando, JS ;
Bohnlein, E ;
Rigg, RJ .
JOURNAL OF VIROLOGICAL METHODS, 1996, 60 (02) :171-178
[10]   Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector [J].
Halene, S ;
Wang, LJ ;
Cooper, RM ;
Bockstoce, DC ;
Robbins, PB ;
Kohn, DB .
BLOOD, 1999, 94 (10) :3349-3357